Clinical Trial

Fermented Dairy Product and Bifidobacterium Diversity

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Bifidobacterium strains with potential health benefits can contribute to the gastrointestinal wellbeing. However, the ability of these strains to survive gastro-intestinal tract stress and their impact on gut microbiome remains to be clarified. This is why the current study aims to assess the impact of Bifidobacteria consumption on human gut microbiome compared to control product.
Trial Details
NCT Number NCT07700381
Lead Sponsor Danone Global Research & Innovation Center
Conditions A03 - Digestive System, B03 - Bacteria
Enrollment 115 participants
Start Date 2026-08
Primary Completion 2026-12 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-14